Regaining compliance with Nasdaq's minimum bid price requirement is a positive development for Gossamer Bio, Inc. It removes the immediate risk of delisting, which can be seen as a vote of confidence from the market. This news is likely to be viewed positively by investors, potentially leading to an increase in stock price in the short term due to reduced uncertainty and improved investor sentiment.